UPC_APP_68693/2024

ANALYTE SENSOR AND APPARATUS FOR INSERTION OF THE SENSOR

Prozessuale & UnteranträgeRücknahmeanträgeNordic-Baltic RDApplication Rop 265—Vergleich erfolgt: Vor Hauptsache

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Abbott Diabetes Care Inc.(Abbott Group)

Vertreter: Wim Maas

Beklagte

Dexcom Inc.(Dexcom Group)
Dexcom International Limited(Dexcom Group)

Vertreter: Tjibbe Douma

Richter

Stefan JohanssonPresiding judge
Kai HärmandJudge-rapporteur
Pierluigi PerrottiLegally qualified judge
Renaud FulconisTechnically qualified judge

Patente

EP 3 977 921

CPC-Codes: A61B5/14865, A61B2560/0475, A61B5/72, A61B5/6898, H04L67/12, A61M2205/33, C12Q1/001, A61B2560/0487, A61B5/14503, A61B5/6849, A61M5/158, A61B5/0004…

Sektor: Biotechnology

Ausgang

Zurückgenommen

Eingereicht: —

Erste Entscheidung: 20. Jan. 2025

Sprache: —

Vergleich erfolgt: Vor Hauptsache

The Nordic-Baltic Regional Division declared the proceedings closed following the mutual withdrawal of Abbott Diabetes Care's infringement action and Dexcom's counterclaim for revocation (both relating to EP 3 977 921). Both parties consented to withdrawal with no cost decision requested or made.